|
The Immunohistochemistry Antibody Company
|
|
|
Head and Neck Cancer Screen 4 Tissue Microarray - LS-SHDCA4This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SHDCA4 |
| Product Name: | Head and Neck Cancer Screen 4 |
| Description: | 18 head & neck cancer with stage/grade and inflammatory specimens: Neck, Oranasopharynx, Larynx, and Salivary Glands |
| Format: | FFPE |
| Category: | Human Tumor and Normal |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 2.5 mm |
| Core Thickness: | 4 µm |
| Cases: | 18 |
| Cores: | 18 |
| Slides Per Set: | 1 |
LS-SHDCA4 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Ear (Ear); Larynx (Lrx); Mouth, Floor (Mth); Nasal cavity (Nsl); Nasopharynx (Nsl); Palate, Hard (Plh); Parotid gland (Pdg); Skin, Nose (Skn); Tongue (Tng); Tonsil (Tsl);
LS-SHDCA4 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification |
|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | F | 48 y | Palate, Hard (Plh) | Adenocarcinoma | Malignant | |
| 1 | A2 | Human | M | 53 y | Mouth, Floor (Mth) | Squamous cell carcinoma | Malignant | T2N0M0 |
| 1 | A3 | Human | F | 43 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | T2N0M0 |
| 1 | A4 | Human | M | 51 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | T4N1M0 |
| 1 | A5 | Human | M | 65 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 |
| 1 | B1 | Human | F | 6 y | Tonsil (Tsl) | Tonsillitis | Inflammatory | |
| 1 | B2 | Human | M | 76 y | Tonsil (Tsl) | Diffuse large B cell lymphoma | Malignant | T1N0M0 |
| 1 | B3 | Human | M | 20 y | Nasal cavity (Nsl) | Hemangioma | Diseased | |
| 1 | B4 | Human | M | 22 y | Nasal cavity (Nsl) | Polyp | Tumor | |
| 1 | B5 | Human | M | 42 y | Nasal cavity (Nsl) | Inverted papilloma | Tumor | |
| 1 | C1 | Human | M | 53 y | Nasal cavity (Nsl) | Melanoma | Tumor | T2N0M0 |
| 1 | C2 | Human | F | 40 y | Nasopharynx (Nsl) | Nasopharyngeal carcinoma | Malignant | T2N1M0 |
| 1 | C3 | Human | M | 65 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant | T1N0M0 |
| 1 | C4 | Human | M | 10 y | Ear (Ear) | Cholesteatoma | Tumor | |
| 1 | C5 | Human | F | 18 y | Parotid gland (Pdg) | Normal | Benign non-neoplastic | |
| 1 | D1 | Human | F | 28 y | Parotid gland (Pdg) | Pleomorphic adenoma | Tumor | |
| 1 | D2 | Human | M | 28 y | Parotid gland (Pdg) | Adenocarcinoma | Malignant | T4N0M0 |
| 1 | D3 | Human | F | 30 y | Parotid gland (Pdg) | Adenoid cystic carcinoma | Malignant | T3N0M0 |